AR096433A1 - Método de tratamiento del cáncer y uso - Google Patents
Método de tratamiento del cáncer y usoInfo
- Publication number
- AR096433A1 AR096433A1 ARP140102081A ARP140102081A AR096433A1 AR 096433 A1 AR096433 A1 AR 096433A1 AR P140102081 A ARP140102081 A AR P140102081A AR P140102081 A ARP140102081 A AR P140102081A AR 096433 A1 AR096433 A1 AR 096433A1
- Authority
- AR
- Argentina
- Prior art keywords
- cancer treatment
- human
- trioxo
- pyrido
- phenylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicación 1: Un método para tratar el cáncer en un ser humano que lo necesite, que comprende la administración in vivo de una cantidad terapéuticamente eficaz de un compuesto seleccionado de N-{3-[3-ciclopropil-5-(2-fluoro-4-yodo-fenilamino)-6,8-dimetil-2,4,7-trioxo-3,4,6,7-tetrahidro-2H-pirido[4,3-d]pirimidin-1-iI]fenil}acetamida, o una de sus sales o solvatos farmacéuticamente aceptables, a dicho ser humano.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361827940P | 2013-05-28 | 2013-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR096433A1 true AR096433A1 (es) | 2015-12-30 |
Family
ID=50884976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140102081A AR096433A1 (es) | 2013-05-28 | 2014-05-26 | Método de tratamiento del cáncer y uso |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR096433A1 (es) |
TW (1) | TW201536292A (es) |
UY (1) | UY35587A (es) |
WO (1) | WO2014191920A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
RS50569B (sr) | 2004-06-11 | 2010-05-07 | Japan Tobacco Inc. | Derivati 5-amino-2,4,7-triokso-3,4,7,8-tetrahidro-2h-pirido (2,3-d)pirimidina i slična jedinjenja za lečenje raka |
-
2014
- 2014-05-26 AR ARP140102081A patent/AR096433A1/es unknown
- 2014-05-26 UY UY35587A patent/UY35587A/es not_active Application Discontinuation
- 2014-05-26 TW TW103118201A patent/TW201536292A/zh unknown
- 2014-05-27 WO PCT/IB2014/061757 patent/WO2014191920A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
TW201536292A (zh) | 2015-10-01 |
WO2014191920A1 (en) | 2014-12-04 |
UY35587A (es) | 2014-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288231A (en) | An inhibitor of jak1/2 or a pharmaceutical salt derived from it and an inhibitor of pi3k or a pharmaceutical salt derived from it, for use in the treatment of myelofibroblasts. | |
ECSP24031979A (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
ECSP17013903A (es) | Protein kinase c inhibitors and methods of their use | |
CR20160130A (es) | Nanopartículas poliméricas terapéuticas y métodos para su elaboración y uso | |
IL258246B (en) | Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer | |
GB201411465D0 (en) | Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer | |
WO2015160975A3 (en) | Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer | |
UY34775A (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis múltiple | |
PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
ECSP14017586A (es) | Derivados de tetrahidro-quinazolinona | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
AR094241A1 (es) | Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
HK1243327A1 (zh) | 包含螺旋藻和棕櫚酰基乙醇酰胺和/或其鹽或藥用上可接受衍生物的組合及其製劑,用於預防和/或治療過度活化的組織病症 | |
CL2019003288A1 (es) | Una combinación farmacéutica para el tratamiento de un cáncer. | |
UY36732A (es) | Piridin pirazinonas novedosas como inhibidores de bromodominios de la familia bet | |
GB2583606C (en) | Indoleamine 2,3-Dioxygenase inhibitors and use of same in medicine | |
AR096433A1 (es) | Método de tratamiento del cáncer y uso | |
AR103484A1 (es) | Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel | |
ES2502140T1 (es) | Comprimidos de liberación inmediata de rasagilina hemitartrato | |
AR095890A1 (es) | Uso de ácido trifluoroacético y sales del mismo para tratar la hipercolesterolemia | |
ES2548927B1 (es) | Derivados de purina como inhibidores de Dapk-1 | |
CL2018001871A1 (es) | Uso de inhibidores de la actividad o función de pi3k para el tratamiento del síndrome de sjögren primario |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |